(Q82353451)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Gene therapy for lung neoplasms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Anil Vachani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Edmund Moon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Elliot Wakeam

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Andrew R Haas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Steven M Albelda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

7 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

Clinics in Chest Medicine

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

865-885

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

15 January 2020

cites work

1 reference

12 December 2020

Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.

1 reference

12 December 2020

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies

1 reference

12 December 2020

Adenovirus-mediated wild-type p53 gene transfer in combination with bronchial arterial infusion for treatment of advanced non-small-cell lung cancer, one year follow-up

1 reference

12 December 2020

Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients.

1 reference

12 December 2020

[Clinical research on recombinant human Ad-p53 injection combined with cisplatin in treatment of malignant pleural effusion induced by lung cancer]

1 reference

12 December 2020

Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers

1 reference

12 December 2020

Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer

1 reference

12 December 2020

Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer

1 reference

12 December 2020

Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer

1 reference

12 December 2020

Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer

1 reference

12 December 2020

Tumor-driven evolution of immunosuppressive networks during malignant progression

1 reference

12 December 2020

Phase I Trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer

1 reference

12 December 2020

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

1 reference

12 December 2020

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

12 December 2020

Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer

1 reference

12 December 2020

Interferon beta adenoviral gene therapy in a patient with ovarian cancer.

1 reference

12 December 2020

Adoptive T cell therapy for cancer in the clinic

1 reference

12 December 2020

A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses

1 reference

12 December 2020

Adenoviral vectors for gene therapy

1 reference

12 December 2020

Requirements for control of B-cell lymphoma by NK cells

1 reference

12 December 2020

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

1 reference

12 December 2020

A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions

1 reference

12 December 2020

Approval of Provenge Seen As First Step for Cancer Treatment Vaccines

1 reference

12 December 2020

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

12 December 2020

A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma

1 reference

12 December 2020

TNFerade, an adenovector carrying the transgene for human tumor necrosis factor alpha, for patients with advanced solid tumors: surgical experience and long-term follow-up

1 reference

12 December 2020

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy

1 reference

12 December 2020

Viral gene therapy strategies: from basic science to clinical application

1 reference

12 December 2020

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer

1 reference

12 December 2020

Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A).

1 reference

12 December 2020

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

1 reference

12 December 2020

A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer.

1 reference

12 December 2020

Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation.

1 reference

12 December 2020

Structure and function of lipid-DNA complexes for gene delivery

1 reference

12 December 2020

Gene-modified PA1-STK cells home to tumor sites in patients with malignant pleural mesothelioma

1 reference

12 December 2020

Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients

1 reference

12 December 2020

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

1 reference

12 December 2020

Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor model

1 reference

12 December 2020

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

1 reference

12 December 2020

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study

1 reference

12 December 2020

A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma.

1 reference

12 December 2020

Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer.

1 reference

12 December 2020

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

1 reference

12 December 2020

Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity

1 reference

12 December 2020

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

1 reference

12 December 2020

A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.

1 reference

12 December 2020

Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy

1 reference

12 December 2020

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

12 December 2020

Gene therapy progress and prospects: nonviral vectors.

1 reference

12 December 2020

Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.

1 reference

12 December 2020

Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma

1 reference

12 December 2020

Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients

1 reference

12 December 2020

Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma.

1 reference

12 December 2020

TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.

1 reference

12 December 2020

Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer

1 reference

12 December 2020

Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer

1 reference

12 December 2020

A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer

1 reference

12 December 2020

Antiviral activity and mechanism of action of ganciclovir

1 reference

12 December 2020

Use of suicide genes in gene therapy

1 reference

12 December 2020

IL-2 gene therapy of advanced lung cancer patients

1 reference

12 December 2020

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

12 December 2020

Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients

1 reference

12 December 2020

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

1 reference

12 December 2020

A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer

1 reference

12 December 2020

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

12 December 2020

Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcino

1 reference

12 December 2020

Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules

1 reference

12 December 2020

Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer

1 reference

12 December 2020

A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients

1 reference

12 December 2020

Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.

1 reference

12 December 2020

Tumor suppressor FUS1 signaling pathway

1 reference

12 December 2020

Safety and efficacy of gene transfer for Leber's congenital amaurosis

1 reference

12 December 2020

Gene therapy of inherited diseases

1 reference

12 December 2020

Recombinant adeno-associated virus transduction and integration

1 reference

12 December 2020

A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancer

1 reference

12 December 2020

Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer

1 reference

12 December 2020

Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597.

1 reference

12 December 2020

Gene therapy using adeno-associated virus vectors

1 reference

12 December 2020

Cancer gene therapy with targeted adenoviruses

1 reference

12 December 2020

Lentiviral vectors for anti-tumor immunotherapy.

1 reference

12 December 2020

Clinical application of lentiviral vectors - concepts and practice

1 reference

12 December 2020

Advanced malignant pleural or peritoneal effusion in patients treated with recombinant adenovirus p53 injection plus cisplatin

1 reference

12 December 2020

10.1016/J.CCM.2011.08.006

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22054892%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

PubMed publication ID

22054892

1 reference